Department of Orthopaedic Surgery, Centre for Orthopaedic Research Alkmaar (CORAL), Northwest Clinics, Wilhelminalaan 12, Alkmaar, 1815 JD, The Netherlands.
Department of Human Movement Sciences, Faculty of Behavioral and Movement Sciences, Amsterdam Movement Sciences, Vrije Universiteit Amsterdam, Van der Boechorststraat 9, Amsterdam, 1081 BT, The Netherlands.
Arch Orthop Trauma Surg. 2024 Aug;144(8):3657-3668. doi: 10.1007/s00402-024-05503-2. Epub 2024 Aug 28.
Hoffa's fat pad is considered a source of anterior knee pain and may limit prosthetic knee function. Resection of Hoffa's fat pad in total knee arthroplasty (TKA), however, is controversial, and little is known about the functional outcomes including gait quality. This double-blind randomized controlled trial (i) compared functional recovery between TKAs where Hoffa was resected or preserved, and (ii) compared recovery of self-reported function with objective (gait-related) outcomes.
Eighty-five patients (age 66.4 ± 8.0 years, 47% women) scheduled to undergo TKA for primary osteoarthritis were randomly assigned to either fat pad resection or preservation. Subjective measures of functioning were assessed at baseline, 6 weeks, 3 months, and 12 months postoperatively and included the Knee Injury and Osteoarthritis Outcome Score (KOOS), Kujala, and visual analog scale (VAS) for pain. Objective measures of functioning were assessed at baseline, 3 months, and 12 months postoperatively and included instrumented range-of-motion and gait analysis. Longitudinal analyses (generalized estimating equations) were used to compare recovery between groups, and chi-square tests compared attainment of minimal clinical important difference (MCID) and patient acceptable symptom state (PASS). Finally, correlation analyses explored associations between subjective and objective recovery in function.
Resection patients showed poorer improvement in KOOS quality of life in the first 6 weeks (B=-10.02, 95% confidence interval (CI) [-18.91, -1.12], p = .027), but stronger improvement in knee extension after 3 months (B = 3.02, 95%CI [0.45, 5.60], p = .021) compared to preservation patients. Regarding MCID or PASS, no differences were noted between groups at 3 and 12 months (all p > .05). Subjective function substantially improved in the first 3 months, while objective outcomes improved only between 3 and 12 months. Moderate to strong correlations were identified between changes in knee flexion and gait with Kujala and KOOS in the resection but not in the preservation group.
Similar functional outcomes were achieved after TKA with or without resection of Hoffa's fat pad. Hence, removing the fat pad to promote surgical exposure will not affect functional outcomes including gait quality. Functional recovery of objective outcomes was not always consistent with subjective recovery, suggesting that both self-reported as well as objective, gait-related outcomes may provide meaningful information on functional recovery following TKA.
This clinical trial was prospectively registered under the Netherlands Trial Registry (# NL3638). This registry has recently been replaced by the Dutch Trial Registry where this study can be accessed via https://onderzoekmetmensen.nl/en/trial/20994 .
Hoffa 脂肪垫被认为是前膝痛的一个来源,并可能限制人工膝关节的功能。然而,在全膝关节置换术(TKA)中切除 Hoffa 脂肪垫存在争议,对于包括步态质量在内的功能结果知之甚少。本双盲随机对照试验(i)比较了切除和保留 Hoffa 脂肪垫的 TKA 之间的功能恢复情况,(ii)比较了自我报告功能的恢复与客观(步态相关)结果。
85 名(年龄 66.4±8.0 岁,47%为女性)计划因原发性骨关节炎行 TKA 的患者被随机分配至脂肪垫切除组或保留组。术后 6 周、3 个月和 12 个月分别评估主观功能,包括膝关节损伤和骨关节炎结果评分(KOOS)、Kujala 和疼痛视觉模拟量表(VAS)。术后 3 个月和 12 个月分别评估客观功能,包括仪器测量的活动范围和步态分析。使用广义估计方程进行纵向分析,以比较组间的恢复情况,卡方检验比较最小临床重要差异(MCID)和患者可接受症状状态(PASS)的达标情况。最后,相关性分析探讨了主观和客观功能恢复之间的关系。
切除组患者在前 6 周的 KOOS 生活质量改善较差(B=-10.02,95%置信区间(CI)[-18.91,-1.12],p=0.027),但在 3 个月后膝关节伸展改善较强(B=3.02,95%CI[0.45,5.60],p=0.021)与保留组相比。在 3 个月和 12 个月时,两组之间的 MCID 或 PASS 均无差异(均 p>0.05)。主观功能在前 3 个月内显著改善,而客观结果仅在 3 至 12 个月之间改善。在切除组中,膝关节屈曲和步态的变化与 Kujala 和 KOOS 之间存在中度至强相关性,但在保留组中则没有。
TKA 时是否切除 Hoffa 脂肪垫均可获得相似的功能结果。因此,为了促进手术暴露而切除脂肪垫不会影响包括步态质量在内的功能结果。客观结果的功能恢复并不总是与主观恢复一致,这表明自我报告和客观的步态相关结果都可能为 TKA 后的功能恢复提供有意义的信息。
该临床试验前瞻性地在荷兰试验注册处(#NL3638)注册。该注册处最近已被荷兰试验注册处取代,该研究可通过以下网址访问 https://onderzoekmetmensen.nl/en/trial/20994。